Detalles de la búsqueda
1.
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
PLoS One
; 15(8): e0238021, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32841306
2.
PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 689-696, 2020.
Artículo
| WPRIM | ID: wpr-831119
Resultados
1 -
2
de 2
1
Próxima >
>>